Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
When faced with surprise expenses, pause, assess impact, and execute a prepped plan: reallocate, delay nonessential spending, and access the buffer.
9,999 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Peloton shares surged on Tuesday after two investor-focused announcements sparked a burst of buying interest. This gu...
A major hedge fund trimmed its ZoomInfo position by millions, fueling questions about the company's prospects. This a...
The Trade Desk declines sharply after softer first-quarter results and a cautious outlook, while AppLovin climbs on s...
SoFi posted stronger Q1 2026 results, but the stock remains depressed as investors weigh the path to sustained profit...
In June, affordable stock ideas can offer surprising upside for patient investors. This article breaks down three und...
A June 17 memorandum between the U.S. and Iran aims to reopen key chokepoints and ease energy markets. Analysts say r...
As software stocks wobble in 2026, one AI-first winner could rise from the noise. This article breaks down why a sele...
May surprised many investors with broad gains across major asset classes. This guide breaks down who led, why, and pr...
Wall Street leaned on a familiar Fed playbook for years. Now a surprising pivot in that script could rattle stocks an...
A renowned market thinker known for optimism outlines a three-phase market path, warning of a near-term correction or...
A recent hotel breakfast incident involving a security guard confronted 11-year-old fans sparked a conversation about...